Viewing Study NCT02575560


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-01 @ 5:37 PM
Study NCT ID: NCT02575560
Status: COMPLETED
Last Update Posted: 2018-02-14
First Post: 2015-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC)
Sponsor: Qingdao Central Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None EGFR-TKI Resistant Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Progression-Free Survival View